Influence of sulfation on platelet aggregation and activation with differentially sulfated hyaluronic acids

Journal of Thrombosis and Thrombolysis

Volumn 6, Issue 2, 1998, Pages 109-115

  Barbucci, Rolando ^a   Lamponi, Stefania ^a   Magnani, Agnese ^a   Poletti, Lawrence F ^b   Rhodes, Nick P ^c   Sobel, Michael ^b   Williams, David F ^c  

^a UNIVERSITY OF SIENA   (Italy)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Heparin like; Platelet activation; Platelet aggregation; Sulfated hyaluronic acid derivatives

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A; FORMALDEHYDE; GLYCOSAMINOGLYCAN; HEPARIN; HYALURONIC ACID DERIVATIVE; POLYSACCHARIDE; RISTOCETIN; THROMBIN; VON WILLEBRAND FACTOR;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDROGEN BOND; PRIORITY JOURNAL; SULFATION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGLUTINATION; THROMBOCYTE AGGREGATION; TURBIDIMETRY;

EID: 0031790404     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008841303634     Document Type: Article

References (34)

1. Rodén L. Heparin, London: Edward Arnold, 1989:240.
2. Hirsh J. Heparin. N Engl J Med 1991;324:1565-1574.
3. Taylor KM. Cardiopulmonary Bypass: Principles and Management, Baltimore, MD: Williams and Wilkins, 1986:105-119.
4. Levine MN, Hirsh J. Hemorrhagic complications of anticoagulant therapy. Semin Thromb Hemost 1986;12:39-57.
5. Salzman EW, Deykin D, Shapiro RM, Rosenberg RD. Management of heparin therapy: Controlled prospective trial. N Engl J Med 1975;292:1046-1050.
6. Holm HA, Abildgaard U, Kalvenes S. Heparin assays and bleeding complications in treatment of deep venous thrombosis with particular reference to retroperitoneal bleeding. Thromb Haemost 1985;53:278-281.
7. Greinacher A, Eckhardt T, Mussmann J, Mueller-Eckhardt C. Pregnancy complicated by heparin associated thrombocytopenia: Management by a prospectively in vitro selected heparinoid (ORG 10172). Thromb Res 1993;71:123-126.
8. Halm MA. Acute gastrointestinal complications after cardiac surgery. Am J Crit Care 1996;5:109-118.
9. Dutton RC, Edmunds LH, Hutchinson JC, Roe BB. Platelet aggregate emboli produced in patients during cardiopulmonary bypass with membrane and bubble oxygenators and blood filters. J Thorac Cardiovasc Surg 1974;67:258-265.
10. Mangano DT, Mangano CM. Perioperative stroke, encephalopathy and CNS dysfunction. J Intensive Care Med 1997;12:148-152.
11. Mora CT, Murkin JM. Cardiopulmonary Bypass: Principles and Techniques of Extracorporeal Circulation, New York: Springer-Verlag, 1995:114-146.
12. Shaw PJ, Bates D, Cartlidge NE, Heaviside D, Julian DG, Shaw DA. Early neurological complication of coronary artery bypass surgery. Br Med J 1985;291:1384-1387.
13. Sotaniemi KA. Cerebral outcome after extracorporeal circulation. Comparison between prospective and retropective evaluation. Arch Neurol 1983;40:75-77.
14. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med 1996;335:1857-1863.
15. Marren SE. Postpump retinopathy. Optom Vis Sci 1994;71: 462-465.
16. 2 on cardiopulmonary bypass-induced lung injury. Perfusion 1994;9:23-33.
17. 2+ ions. Gazz Chim Ital 1995;125:169-180.
18. Magnani A, Albanese A, Lamponi S, Barbucci R. Blood-interaction performance of differently sulphated hyaluronic acids. Thromb Res 1996;81:383-395.
19. Kelton JG, Bishop J, Carter CJ, Hirsh J. A comparison of the quantitative ristocetin von Willebrand factor assay by using fresh and fixed platelets. Thromb Res 1980;18:477-483.
20. Ruggeri ZM. Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemost 1993;70:119-123.
21. 1746 sequence in the GPIIb/IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium. J Lab Clin Med 1993;122:324-332.
22. Mulvihill JN, Cazenave JP. Platelet adhesion to surfaces. In: The Role of Platelets in Blood-Biomaterial Interactions. YF Missirilis, JL Wautier (eds.) Dordrecht: Kluwer Academic Publishers, 1993:69-80.
23. Kieffer N. Structure and function of platelet membrane glycoproteins. YF Missirilis, JL Wautier (eds.) In: The Role of Platelets in Blood-Biomaterial Interactions. Dordrecht: Kluwer Academic Publishers, 1993:15-32.
24. Ault KA. Clinical Flow Cytometry: Principles and Application. Baltimore, MD: Williams and Wilkins, 1993:387-403.
25. Okano T, Shimada M, Shinohara I, Kataoka K, Akaike T, Sakurai Y. Biomaterials 1980. London: John Wiley, 1982: 445-450.
26. Bowry SK, Courtney SM, Prentice CRM, Douglas JT. Utilization of the platelet release reaction in the blood compatibility assessment of polymers. Biomaterials 1984;5:289-292.
27. Umemura Y, Huskey RA, Anderson JM. Human platelet interactions with surfaces of type I collagen, chondroitin-4-sulphate and chondroitin-6-sulphate in vitro. Biomaterials 1988;9:133-137.
28. Leake DL, Cenni E, Cavedagna D, Stea S, Ciapetti G, Pizzoferrato A. Comparative study of the thromboresistance of Dacron® combined with various polyurethanes Biomateri-als 1989;10:441-444.
29. Rhodes NP, Zuzel M, Williams DF, Derrick MR. Granule secretion markers on fluid-phase platelets in whole blood perfused through capillary tubing. J Biomed Mater Res 1994;28:435-439.
30. Ault KA, Rinder HM, Mitchell JG, Rinder CS, Lambrew CT, Hillman RS. Correlated measurement of platelet release and aggregation in whole blood. Cytometry 1989;10:448-455.
31. Sobel M, McNeill PM, Carlson PL, et al. Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo. J Clin Invest 1991;87:1787-1793.
32. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987;70:307-315.
33. Fijnheer R, Modderman PW, Veldman H, et al. Detection of platelet activation with monoclonal antibodies and flow cytometry. Transfusion 1990;30:20-25.
34. Sobel M, Soler DF, Kermode JC, Harris RB. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J Biol Chem 1992;267:8857-8862.